Besides presenting as mitochondrial myopathy, TK2 mutations may also be associated with other clinical manifestations, including sensorineural hearing loss, PEO/PMM with multiple mtDNA deletions, early-onset encephalopathy, SMA-like phenotype, and multisystemic involvement [28–30]. Here, TK2 is linked to Encephalopathy.